Meizu m3 note Launched in India: Price, Specifications, and More

Meizu has launched m3 note in India, priced at Rs. 9,999. The smartphone will be available in its first sale on May 31 via Amazon India, with registrations beginning from Wednesday 2pm IST. To recall, Meizu had launched two variants of the m3 note in China, one with 2GB of RAM and 16GB of inbuilt storage, and the… Read More »

Smartron t.phone India Launch Set for May 19 Event

IoT startup Smartron has sent out media invites for the launch of its upcoming smartphone t.phone in India. Smartron unveiled the t.phone in April alongside the launch of the t.book, but never revealed its complete specifications, pricing, or availability. The smartphone will now be launched on May 19. Smartron is an IoT startup founded in 2014 by Mahesh… Read More »

Mitsubishi Motors says improper data may have been used for more models

Mitsubishi Motors Corp (7211.T) said on Wednesday that improper data for mileage calculations might have been used for other models in addition to those it has already disclosed. The Japanese carmaker last month admitted to overstating the fuel economy readings in four of its mini-vehicle models. On Wednesday, it said it suspected improper data was used for models… Read More »

Dollar dips from two-week high, stocks in the red

The dollar fell on Wednesday, succumbing to a bout of profit-taking after hitting a two-week high the previous day, while European stocks also put a positive start to the week behind them to trade in the red. Weak corporate earnings weighed on stocks, as Germany’s DAX .GDAXI snapped a four-day winning streak and the broader FTSEuroFirst 300 index… Read More »

Marshmallow starts hitting Galaxy S5 Plus as well

With the Galaxy S5 smartphone receiving the Marshmallow update in several regions around the world, Samsung – it seems – has now shifted its attention to the Plus variant, as the update is now available for units (SM-G901F) in Germany. Launched back in 2014 as a Snapdragon 805-powered variant of the Galaxy S5 flagship, the S5 Plus received… Read More »

Facebook has 50 minutes of your time each day and it wants more

Facebook reported dazzling first quarter results last week: Net income nearly tripled to $1.5 billion, and monthly active users hit a record 1.65 billion. But it’s a much smaller number that leapt out at me. Fifty minutes. That’s the average amount of time, the company said, that users spend each day on its Facebook, Instagram and Messenger platforms… Read More »

Facebook ‘Reactions’ still to find takers: Study

 The additional “Reaction” buttons that social media giant Facebookintroduced next to the “Like” button this year have failed to charm users, a study has found. The study by social media analytics and benchmarking tool for professionals Quintly found that “Reaction” emoticons are underused till date. Quintly filtered 130,000 posts and found that users rarely take the time to… Read More »

Super PAC forms unit to confront Clinton critics on social media

Beware of saying anything bad about Hillary Clinton online – you may end up confronted by a multimillion-dollar super PAC working to shut you down on social media. The Los Angeles Times reports that Correct the Record – run by Clinton ally David Brock – is spending a million dollars to challenge social media users tweeting and posting negative… Read More »

Report Claiming Bias in Facebook ‘Trending’ Topics Sparks Social Media Outcry

Facebook workers often omitted conservative political stories from the website’s “trending” list, the technology news site Gizmodo said on Monday in a report that sparked widespread comment on social media. An unnamed former Facebook employee told Gizmodo that workers “routinely suppressed news stories of interest to conservative readers,” according to Gizmodo, while “artificially” adding other stories into the… Read More »

Allergan profit beats on strong sales of Botox and Restasis

Allergan Plc (AGN.N), whose $160 billion merger with Pfizer Inc (PFE.N) fell apart last month, reported a better-than-expected quarterly profit on Tuesday, led by strong sales of wrinkle treatment Botox and eye drug Restasis. Allergan, known as Actavis Inc until it bought Botox-maker Allergan Inc last year and took on its name, also said its board had authorized… Read More »